Both in Biotechnology
Aura Biosciences vs Ginkgo Bioworks Holdings
Over the past year AURA returned +0.2% and DNA returned −13.7%; their daily moves had a correlation of 0.22.
AURA +0.2% DNA −13.7%Growth of $1, one year, split-adjusted
| Metric | AURA | DNA |
|---|---|---|
| Price | $6.14 | $11.21 |
| Market cap | $636.7M | $754.9M |
| Today | −2.46% | −12.01% |
| 1 month | +1.7% | −10.3% |
| 6 months | −12.4% | +15.6% |
| Year to date | +12.7% | +34.9% |
| 1 year | 0.0% | −8.0% |
| Revenue growth (YoY) | — | −48.5% |
| Gross margin | — | 91.5% |
| Net margin | — | −231.7% |
| P/E (TTM) | — | — |
| Price / sales | — | 6.7× |
| Net cash | $323.8M | $302.2M |
| Dividend yield | — | — |
| Volatility (60d) | 41.6% | 125.2% |
| Short % of float | 11.8% | 18.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).